[
  {
    "title": "Assessing Chugai Pharmaceutical (TSE:4519) Valuation Following Strong Share Price Gains",
    "link": "https://finance.yahoo.com/news/assessing-chugai-pharmaceutical-tse-4519-221251646.html",
    "publisher": "Simply Wall St.",
    "date": "2025-11-11T22:12:51Z",
    "type": "STORY"
  },
  {
    "title": "Chugai acquires Renalys, enhancing its kidney disease portfolio",
    "link": "https://www.pharmaceutical-technology.com/news/chugai-renalys-kidney/",
    "publisher": "Pharmaceutical Technology",
    "date": "2025-10-27T10:58:17Z",
    "type": "STORY"
  },
  {
    "title": "H.C. Wainwright Initiates Rani Therapeutics (RANI) with Buy and $11 PT on RaniPill Potential",
    "link": "https://finance.yahoo.com/news/h-c-wainwright-initiates-rani-100552405.html",
    "publisher": "Insider Monkey",
    "date": "2025-10-26T10:05:52Z",
    "type": "STORY"
  },
  {
    "title": "Chugai Pharmaceutical (TSE:4519): Valuation Discount and Margin Dip Set Stage for Earnings Season",
    "link": "https://finance.yahoo.com/news/chugai-pharmaceutical-tse-4519-valuation-210745102.html",
    "publisher": "Simply Wall St.",
    "date": "2025-10-25T21:07:45Z",
    "type": "STORY"
  },
  {
    "title": "Chugai buys a kidney biotech; ICER targets rising launch prices",
    "link": "https://www.biopharmadive.com/news/chugai-renalys-icer-prices-arcturus-terns-summit/803501/",
    "publisher": "BioPharma Dive",
    "date": "2025-10-24T08:58:00Z",
    "type": "STORY"
  },
  {
    "title": "Trending tickers: Apple, Beyond Meat, Rani Therapeutics, BitMine and B&M",
    "link": "https://uk.finance.yahoo.com/news/apple-beyond-meat-rani-therapeutics-bitmine-bm-trending-tickers-105334622.html",
    "publisher": "Yahoo Finance UK",
    "date": "2025-10-20T10:53:34Z",
    "type": "STORY"
  },
  {
    "title": "Rani Therapeutics (RANI): Examining Valuation After Landmark Chugai Deal and $60M Funding Boost",
    "link": "https://finance.yahoo.com/news/rani-therapeutics-rani-examining-valuation-031014276.html",
    "publisher": "Simply Wall St.",
    "date": "2025-10-20T03:10:14Z",
    "type": "STORY"
  },
  {
    "title": "Rani Therapeutics (RANI) Is Up 257.9% After $1.08 Billion Chugai Deal and $60M Fundraise—What’s Changed",
    "link": "https://finance.yahoo.com/news/rani-therapeutics-rani-257-9-180719432.html",
    "publisher": "Simply Wall St.",
    "date": "2025-10-18T18:07:19Z",
    "type": "STORY"
  },
  {
    "title": "Top Midday Gainers",
    "link": "https://finance.yahoo.com/news/top-midday-gainers-175850328.html",
    "publisher": "MT Newswires",
    "date": "2025-10-17T17:58:50Z",
    "type": "STORY"
  },
  {
    "title": "Rani Therapeutics Enters Into Up to $1.09 Billion Collaboration, License Deal With Chugai Pharmaceutical -- Shares Rise Premarket",
    "link": "https://finance.yahoo.com/news/rani-therapeutics-enters-1-09-123119617.html",
    "publisher": "MT Newswires",
    "date": "2025-10-17T12:31:19Z",
    "type": "STORY"
  }
]